Medsider: Learn from Medtech and Healthtech Founders and CEOs

In this episode of Medsider Radio, we sat down with Dr. Sudhir Srivastava , founder, chairman, and CEO of SS Innovations (Nasdaq: SSII) .  The company’s SSi Mantra surgical robotic system supports a variety of surgical robotic procedures, including cardiac surgery.  Sudhir brings more than three decades of experience in minimally invasive and robotic cardiac interventions, having served as Directo...

In this episode of Medsider Radio, we sat down with Aditya Rajagopal , co-founder and CEO of Esperto Medical . Esperto is a Caltech spin-out utilizing compressed sensing technology with ultrasound to continuously and non-invasively measure blood pressure. Before Esperto, Aditya co-founded ChromaCode, a molecular diagnostics company, and was a researcher at Google[x], where he worked on novel medic...

In this episode of Medsider Radio, we sat down with Eric Kau , co-founder and CEO of Climatic . Climatic is commercializing L Max, a daily inhaled system that proactively supports lung function. Before Climatic, Eric served as COO of Seed Health and was part of the foundational team at Chewy. Earlier in his career, Eric held growth and operational leadership roles across consumer, wellness, and e-...

In this episode of Medsider Radio, we sat down with Kara Egan , founder and CEO of Teal Health . Teal Health is the company behind the first FDA-authorized at-home cervical cancer screening wand. Before founding Teal, Kara worked in healthcare and software investing at .406 Ventures and Emergence Capital, and held product and marketing roles at Zendesk and Stitch Labs.   In this interview, Kara di...

In this episode of Medsider Radio, we sat down with Karthik Ganesh , CEO of OnMed . OnMed is the healthcare technology company behind OnMed CareStation, a “Clinic-in-a-Box” designed to expand access to primary and urgent care.  Before OnMed, Karthik served as CEO of EmpiRx Health, leading the company through rapid growth and a successful private equity transaction in 2021. Throughout his career, h...

In this episode of Medsider Radio, we sat down with Dr. Connie Lehman , founder and CEO of Clairity . Clairity is the first FDA-authorized AI platform that predicts a woman's five-year risk of developing breast cancer using only a routine screening mammogram. A physician scientist with over 300 peer-reviewed publications, Connie is a Professor of Radiology at Harvard Medical School and Breast Imag...

In this episode of Medsider Radio, we sat down with Antony Odell , co-founder and CEO of Echopoint Medical . Echopoint is a London-based UCL spinout developing iKOr, an optical microcatheter for coronary diagnostics. Antony brings over 30 years of medtech experience across Johnson & Johnson, Fresenius, and Stryker, before transitioning into startups as CEO of Tayside Flow Technologies and Tiss...

In this episode of Medsider Radio, we sat down with Kurt Jacobus , co-founder and CEO of restor3d . restor3d provides patient-specific orthopedic implants using 3D printing and advanced software. Kurt has over two decades of experience in medtech entrepreneurship, including successful exits to Enovis and NuVasive. Prior to his career in medical devices, Kurt was a consultant at McKinsey & Comp...

In this episode of Medsider Radio, we sat down with Alfred Griffin , co-founder and CEO of LightForce . LightForce is the developer of the world's first fully customized 3D-printed bracket system directly personalized for each patient's digital treatment plan. Alfred holds a DMD and PhD in Craniofacial Biology from the Medical University of South Carolina and completed his orthodontic residency at...

In this episode of Medsider Radio , we sat down with Laura Yecies , CEO of Osteoboost . Osteoboost is the first FDA-cleared drug-free prescription treatment for osteopenia in postmenopausal women. Laura brings over 30 years of experience across technology, digital health, and medical innovation, with a focus on overlooked gaps in women's health. She previously served as CEO of SugarSync (acquired...

In this episode of Medsider Radio , we sat down with Stephen Belcher , co-founder and CEO of Secure Closure . Secure Closure is developing Quattro-Close, a device designed for large-bore femoral access sites. Trained as a veterinarian, Stephen has spent more than 25 years in the medical device industry, with deep experience in vascular access and closure technologies. He previously held commercial...

In this episode of Medsider Radio , we sat down with Daniel Estay , founder and CEO of SonoVascular . SonoVascular has developed a novel mechanical-pharmaco ultrasound facilitated thrombectomy system, SonoThrombectomy, that utilizes microbubble-mediated cavitation as a core enabling mechanism to remove blood clots more effectively. Dan has over 35 years of global medtech experience, including busi...

In this episode of Medsider Radio , we sat down with Matthias Hofmann , CEO of Eyebot . Eyebot is commercializing retail kiosks that deliver quick, efficient vision testing. Before Eyebot, Matthias led product development at Formlabs and served as an R&D lead at EyeNetra, where he helped bring the first smartphone-based vision test to market. He holds a Ph. D. in Electrical Engineering with gr...

In this episode of Medsider Radio , we sat down with Massimiliano (Max) Colella , CEO of CMR Surgical . CMR Surgical is developing Versius, a surgical robot designed to make minimally invasive procedures more accessible across specialties. Max brings more than three decades of healthcare leadership experience spanning medtech and hospital systems. He previously held leadership roles at Johnson &am...

In this episode of Medsider Radio , we sat down with Rick Bente , co-founder and CEO of Indomo . Indomo’s flagship device, ClearPen, is an investigational at-home corticosteroid injection designed to treat inflammatory acne. Rick has over 20 years of experience as an engineer and operator across medtech and pharma, with leadership roles at Medtronic, Insulet, and YourBio, focused on drug delivery...

In this episode of Medsider Radio , we sat down with Shaun Bagai , CEO of RenovoRx .  The company is developing targeted oncology therapies and is currently commercializing RenovoCath, which is focused on pancreatic cancer.  Before joining RenovoRx in 2014, Shaun spent over a decade in the cardiovascular space, including leading global market development at HeartFlow and helping establish the Euro...

In this episode of Medsider Radio , we sat down with Justin Zenanko , co-founder & CEO of SynerFuse . SynerFuse is developing the e-TLIF procedure, which combines spinal fusion with neuromodulation by placing leads directly at exposed nerves during surgery. A certified public accountant and serial entrepreneur, Justin previously served as CFO and senior vice president of corporate development...

In this episode of Medsider Radio , we sat down with Marina Pavlovic Rivas , co-founder & CEO of Eli Health . The company is focused on making hormone data accessible in real time through its saliva-based testing system that delivers results through a mobile app.  A data scientist by training, Marina previously founded Gradiant AI, a machine learning company that was acquired in 2019.  In this...

In this episode of Medsider Radio , we sat down with Greg Walters , co-founder & CEO of Excision Medical . Excision is developing a leaflet modification system to enable lifetime management of aortic stenosis. Greg has almost 40 years of experience in cardiovascular devices, holding leadership roles at Kensey Nash Corporation where he led the development of Angio-Seal and several endovascular...

In this episode of Medsider Radio , we sat down with Jaeson Bang , Founder & CEO of Future Cardia . Future Cardia is developing a subcutaneous heart-failure monitoring platform designed to capture both electrical and mechanical cardiac signals through a simple office-based procedure. Jaeson brings more than two decades of experience building implantable cardiac technologies across Medtronic, C...

In this episode of Medsider Radio , we sat down Dr. Adam Kadlec , practicing urologist and co-founder of Rivermark Medical . Rivermark is a clinical-stage company developing FloStent, a first-line, reversible device therapy for benign prostatic hyperplasia (BPH). Before launching Rivermark, Adam built a thriving urological practice in Milwaukee and consulted for several device companies — experien...

In this episode of Medsider Radio , we sat down with Andrew Holman , MD, CEO of Inmedix . Inmedix is commercializing CloudHRV, an FDA-cleared diagnostic that quantifies biological stress with clinical precision to guide treatment decisions in autoimmune disease and beyond. Andrew is a practicing rheumatologist in Seattle with 25 years of clinical and research experience. His discoveries linking au...

In this episode of Medsider Radio , we sat down with Colby Holtshouse , President and CEO of May Health. May Health is developing a minimally invasive ovarian ablation therapy designed to restore ovulation in women with polycystic ovary syndrome (PCOS) and PCOS-related infertility. Before May Health, Colby served as Global Medtech Commercial Lead at Organon, overseeing the worldwide launch of the...

In this episode of Medsider Radio , we sat down with Kaitlin Maier , co-founder and CEO of Reia . Reia has developed a self-managed pessary — a collapsible device that empowers women to treat pelvic organ prolapse comfortably and independently. A mechanical engineering graduate of Dartmouth, Kaitlin previously worked at Sherpa Technology Group, developing patent strategies for leading life science...

In this episode of Medsider Radio , we sat down with Somer Baburek , CEO and co-founder of Hera Biotech . Hera is developing AI-driven tissue diagnostics for conditions that disproportionately affect women, including endometriosis and cervical cancer. Before launching Hera, Somer spent nearly a decade in venture capital, where she evaluated early-stage medtech startups and learned what separates t...